mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.03 |
mRNA |
FGIN-1-27 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.03 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |
mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.04 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.04 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.04 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.04 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.04 |
mRNA |
BRD-K86535717 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.05 |